Point-of-care testing of international normalized ratio for patients on oral anticoagulant therapy project protocol
This health technology assessment (HTA) will inform decisions regarding the accuracy, and clinical and cost-effectiveness of point-of-care (POC) International Normalized Ratio (INR) compared with standard laboratory testing, and compared with other POC INR devices. A systematic review to evaluate th...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
Canadian Agency for Drugs and Technologies in Health
2013, 2013
|
| Series: | CADTH optimal use report
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This health technology assessment (HTA) will inform decisions regarding the accuracy, and clinical and cost-effectiveness of point-of-care (POC) International Normalized Ratio (INR) compared with standard laboratory testing, and compared with other POC INR devices. A systematic review to evaluate the clinical effectiveness of POC INR compared with laboratory methods, and other POC INR devices, followed by a review of economic evaluation studies will be conducted. CADTH will also conduct a primary economic analysis of the cost-effectiveness of POC INR from a Canadian perspective |
|---|---|
| Physical Description: | 1 PDF file (i, 13 pages) |